Drug Trial Radar · NCT07112378
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Nov 10, 2025
Primary completion
Jun 19, 2028
Study completion Oct 9, 2028
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- Collaborators
- Sanofi
- First posted
- Aug 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called dupilumab (called "study drug"). The study is focused on children with active eosinophilic esophagitis (EoE; an inflammatory disease of the esophagus) which impacts feeding and nourishment. The aim of the study is to see how safe, tolerable, and effective the study drug is when given for 24 weeks to children with active EoE. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
Conditions
- Eosinophilic Esophagitis (EoE)
Interventions
dupilumabDrug
Administered as defined in the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent Serious Adverse Events (SAEs)Time frame: Up to 24 Weeks
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
University of California San Francisco (UCSF)
San Francisco, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
GI Care for Kids LLC
Atlanta, Georgia · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Weill Cornell Medicine
New York, New York · Recruiting
University of North Carolina, Bioinformatics Building
Chapel Hill, North Carolina · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Medical University of South Carolina
Charleston, South Carolina · Recruiting
Cook Children's Medical Center
Fort Worth, Texas · Recruiting
University of Virginia
Charlottesville, Virginia · Recruiting
Seattle Children's Hospital
Seattle, Washington · Recruiting
Medical College of Wisconsin, Children's Hospital of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.